MeadWestvaco Corporation (MWV) announced a licensing agreement with Burgopak Ltd. MWV Healthcare will market Burgopak’s award-winning medication adherence packaging, serving the pharmaceutical and animal health markets in the United States.
ByLesprom Network
Jun 03, 2015. /Lesprom Network/. MeadWestvaco Corporation (MWV) announced a licensing agreement with
Burgopak Ltd. MWV Healthcare will market Burgopak’s award-winning medication
adherence packaging, serving the pharmaceutical and animal health markets in
the United States.
Patient medication adherence is a globally recognized challenge, with an
estimated 50% of patients not taking their medication as prescribed.
Collaborative action to address this challenge is growing rapidly across
diverse corners of the healthcare sector, including within the pharmaceutical
industry.
“This is a natural partnership of two businesses that have made a clear
strategic commitment to improving medication adherence through packaging,” said
John Grinnell, vice president and managing director, MWV Healthcare, Secondary
and Adherence.
MeadWestvaco Corporation (MWV) is a global packaging company.
Our website uses cookies to make your browsing experience better and more personal. By using our site, you agree to our use of cookies. You can read our Cookie Policy and Privacy Policy.This website uses 'cookies' to give you the best, most relevant experience. You can read our Cookie Policy and Privacy Policy.